144 related articles for article (PubMed ID: 15302308)
41. Aromatase inhibitors: potential reproductive implications.
Bedaiwy MA; Mousa NA; Casper RF
J Minim Invasive Gynecol; 2009; 16(5):533-9. PubMed ID: 19608462
[TBL] [Abstract][Full Text] [Related]
42. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri.
Davis SR
J Clin Endocrinol Metab; 1997 Feb; 82(2):702-3. PubMed ID: 9024281
[No Abstract] [Full Text] [Related]
43. [GnRH analogues and myomas: against but...].
Fernandez H
Gynecol Obstet Fertil; 2005 Dec; 33(12):1019-22. PubMed ID: 16314135
[No Abstract] [Full Text] [Related]
44. The use of gonadotrophin-releasing hormone analogues in gynaecology.
Lo KW; Lau TK
Chin Med J (Engl); 1997 Oct; 110(10):746-9. PubMed ID: 9642302
[No Abstract] [Full Text] [Related]
45. [Surgical treatment of subserosal fibroids: the pros].
Gillaux C; Panel P
Gynecol Obstet Fertil; 2011; 39(7-8):458-61. PubMed ID: 21752684
[No Abstract] [Full Text] [Related]
46. [GnRH analogues and myomas: which strategy?].
Cohen J
Gynecol Obstet Fertil; 2006 May; 34(5):462. PubMed ID: 16630742
[No Abstract] [Full Text] [Related]
47. Pulmonary benign metastasizing leiomyoma: a report of 2 cases with different outcomes.
Benetti-Pinto CL; Soares PM; Petta CA; De Angelo-Andrade LA
J Reprod Med; 2006 Sep; 51(9):715-8. PubMed ID: 17039701
[TBL] [Abstract][Full Text] [Related]
48. [Morphometric and histological evaluation of uterine leiomyomas treated with GnRH agonists or progestational agents].
Resta L; Sanguedolce F; Orsini G; Laricchia L; Piscitelli D; Fiore MG
Pathologica; 2004 Apr; 96(2):35-41. PubMed ID: 15449444
[TBL] [Abstract][Full Text] [Related]
49. [Clinical pathogenetic variants in the growth and development of a uterine myoma].
Dondukova TM; Kats EI
Akush Ginekol (Mosk); 1980 Jan; (1):21-3. PubMed ID: 7377469
[No Abstract] [Full Text] [Related]
50. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder.
Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I
Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092
[TBL] [Abstract][Full Text] [Related]
51. A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata.
Chwalisz K; Larsen L; Mattia-Goldberg C; Edmonds A; Elger W; Winkel CA
Fertil Steril; 2007 Jun; 87(6):1399-412. PubMed ID: 17307170
[TBL] [Abstract][Full Text] [Related]
52. Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial.
Coddington CC; Grow DR; Ahmed MS; Toner JP; Cook E; Diamond MP
Fertil Steril; 2009 May; 91(5):1909-13. PubMed ID: 18439584
[TBL] [Abstract][Full Text] [Related]
53. GnRH-antagonists in reproductive medicine.
Griesinger G; Felberbaum R; Diedrich K
Arch Gynecol Obstet; 2005 Dec; 273(2):71-8. PubMed ID: 15991015
[TBL] [Abstract][Full Text] [Related]
54. Effects of raloxifene in a guinea pig model for leiomyomas.
Porter KB; Tsibris JC; Porter GW; Fuchs-Young R; Nicosia SV; O'Brien WF; Spellacy WN
Am J Obstet Gynecol; 1998 Nov; 179(5):1283-7. PubMed ID: 9822517
[TBL] [Abstract][Full Text] [Related]
55. Fibroids (uterine myomatosis, leiomyomas).
Lethaby A; Vollenhoven B
Clin Evid; 2003 Jun; (9):2028-43. PubMed ID: 15366172
[No Abstract] [Full Text] [Related]
56. [The use of a gonadotropin-releasing hormone agonist for treating gynecological diseases].
Merser LJ; Jilbert HM; Chen P
Akush Ginekol (Mosk); 1991 Feb; (2):16-20. PubMed ID: 1862845
[No Abstract] [Full Text] [Related]
57. Fibroids (uterine myomatosis, leiomyomas).
Lethaby A; Vollenhoven B
Clin Evid; 2004 Jun; (11):2406-26. PubMed ID: 15652116
[No Abstract] [Full Text] [Related]
58. Fibroids (uterine myomatosis, leiomyomas).
Lethaby A; Vollenhoven B
Clin Evid; 2005 Dec; (14):2264-82. PubMed ID: 16620489
[No Abstract] [Full Text] [Related]
59. Ambulatory management of uterine leiomyomata.
Barbieri RL
Clin Obstet Gynecol; 1999 Jun; 42(2):196-205. PubMed ID: 10370841
[No Abstract] [Full Text] [Related]
60. Rapid endometrial preparation for hysteroscopic surgery with oral desogestrel plus vaginal raloxifene: a prospective, randomized pilot study.
Cicinelli E; Pinto V; Tinelli R; Saliani N; De Leo V; Cianci A
Fertil Steril; 2007 Sep; 88(3):698-701. PubMed ID: 17678902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
